Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells

Molecular Cancer Therapeutics

Volumn 1, Issue 12, 2002, Pages 1043-1049

  Takenobu, Toshihiko ^a,b   Tomizawa, Kazuhito ^a   Matsushita, Masayuki ^a   Li, Sheng Tian ^a   Moriwaki, Akiyoshi ^a   Lu, Yun Fei ^c   Matsui, Hideki ^a,c  

^a OKAYAMA UNIVERSITY   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; HYBRID PROTEIN; PEPTIDE; POLYARGININE; PROTEIN P53;

ACTIVE TRANSPORT; ADENOVIRUS; APOPTOSIS; ARTICLE; CELL DIVISION; CELL MEMBRANE; CELL NUCLEUS; CELL SURVIVAL; CHEMISTRY; FLUORESCENCE MICROSCOPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; PLASMID; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; TIME; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; CELL MEMBRANE; CELL NUCLEUS; CELL SURVIVAL; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MOUTH NEOPLASMS; PEPTIDES; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037680428     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Verma, I. M., and Somia, N. Gene therapy - promises, problems and prospects. Nature (Lond.), 389: 239-242, 1997. (Pubitemid 27406627)
2. Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D., and Pavlakis, G. N. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol., 15: 647-652, 1997. (Pubitemid 27291165)
3. Templeton, N. S., and Lasic, D. D. New directions in liposome gene delivery. Mol. Biotechnol., 11: 175-180, 1999. (Pubitemid 29404186)
4. Pirollo, K. F., Xu, L., and Chang, E. H. Non-viral gene delivery for p53. Curr. Opin. Mol. Ther., 2: 168-175, 2000. (Pubitemid 30212266)
5. Green, M., and Loewenstein, P. M. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell, 55: 1179-1188, 1988. (Pubitemid 19020070)
6. Frankel, A. D., and Pabo, C. O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell, 55: 1189-1193, 1988. (Pubitemid 19020071)
7. Schwarze, S. F., Hruska, K. A., and Dowdy, S. F. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol., 10: 290-295, 2000. (Pubitemid 30387038)
8. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med., 4: 1449-1452, 1998. (Pubitemid 28553472)
9. Vocero-Akbani, A., Heyden, N. A., Lissy, N. A., Ratner, L., and Dowdy, S. F. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat. Med., 5: 29-33, 1999. (Pubitemid 29050995)
10. Kwon, H. Y., Eum, W. S., Jang, H. W., Kang, J. H., Ryu, J., Lee, B. R., Jin, L. H., Park, J., and Choi, S. Y. Transduction of Cu,Zn-superoxide dismutase mediated by a HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett., 485: 163-167, 2000.
11. Schwarze, S. R., Ho., A., Vocero-Akbani, A., and Dowdy, S. F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (Wash. DC), 285: 1569-1572, 1999. (Pubitemid 29420581)
12. Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., and Khavari, P. A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med., 6: 1253-1257, 2000.
13. Wender, P., Mitchell, D., Pattabiraman, K., Pelkey, E., Steinman, L., and Rothbard, J. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptide molecular transporters. Proc. Natl. Acad. Sci. USA, 97: 13003-13008, 2000.
14. Matsushita, M., Tomizawa, K., Moriwaki, A., Li, S-T., Terada, H., and Matsui, H. A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J. Neurosci., 21: 6000-6007, 2001. (Pubitemid 32737733)
15. Kanegae, Y., Makimura, M., and Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol., 47: 157-166, 1994. (Pubitemid 24330700)
16. Tomizawa, K., Matsui, H., Matsushita, M., Lew, J., Tokuda, M., Itano, T., Konishi, R., Wang, J. H., and Hatase, O. Localization and developmental changes in the neuron-specific cyclin-dependent kinase 5 activator (p35nck5a) in the rat brain. Neuroscience, 74: 519-529, 1996. (Pubitemid 26274221)
17. Taniura, H., Matsumoto, K., and Yoshokawa, K. Physical and functional interactions of neuronal growth suppressor nectdin with p53. J. Biol. Chem., 274: 16242-16248, 1999.
18. Ji, Z. W., Oku, N., Umeda, M., and Komori, T. Establishment of an oral squamous cell carcinoma cell line (NOS-1) exhibiting amplification of the erbB-1 oncogene and point mutation of p53 tumor suppressor gene: its biological characteristics and animal model of local invasion by orthotopic transplantation of the cell line. Oral Oncol., 37: 386-392, 2001. (Pubitemid 32391386)
19. Rodriguez, M. S., Desterro, J. M. P., Lain, S., Lane, D. P., and Hay, R. T. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome- mediated degradation. Mol. Cell. Biol., 20: 8458-8467, 2000.
20. Kanata, H., Yane, K., Ota, I., Miyahara, H., Matsunaga, T., Takahashi, A., Ohnishi, K., Ohnishi, T., and Hosoi, H. CDDP induces p53-dependent apoptosis in tongue cancer cells. Int. J. Oncol., 17: 513-517, 2000.
21. Sakai, E., and Tsuchida, N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 7: 927-933, 1992.
22. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Wash. DC), 266: 807-810, 1994. (Pubitemid 24359290)
23. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994. (Pubitemid 24138709)
24. Swisher, S. G., Roth, J. A., Nemunaitis, J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El-Naggar, A. K., Fossella, F., Glisson, B. S., Hong, W. K., Khuri, F. R., Kurie, J. M., Lee, J. J., Lee, J. S., Mack, M., Merritt, J. A., Nguyen, D. M., Nesbitt, J. C., Perez-Soler, R., Pisters, K. M., Putnam, J. B., Jr., Richli, W. R., Savin, M., and Waugh, M. K. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst., 91: 763-771, 1999. (Pubitemid 29239055)
25. Jin, L. H., Bahn, J. H., Eum, W. S., Kwon, H. Y., Jang, S. H., Han, K. H., Kang, T. C., Won, M. H., Kang, J. H., Cho, S. W., Park, J., and Choi, S. Y. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radical Biol. Med., 31: 1509-1519, 2001. (Pubitemid 33145321)
26. Mukhopadhyay, T., and Roth, J. A. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene, 17: 241-246, 1998. (Pubitemid 28371898)